AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18047523 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab (80 mg subcutaneously at week 0, then 40 mg every other week)
Number of subjects: 271
Study 18047523 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (7.5 mg orally, increased as needed to 25 mg weekly)
Number of subjects: 271
Study 18047523 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 271
Study 18047523 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 271
Study 18047523 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate
Number of subjects: 271
Study 16416458 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 61
Study 16416458 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 61
Study 12892868 — intervention group
Group type: EXPERIMENTAL
Intervention: S-QoL questionnaire
Number of subjects: 207
Study 10848924 — intervention group
Group type: EXPERIMENTAL
Intervention: Pranlukast (225 mg orally twice daily for 4 weeks)
Number of subjects: 32
Study 10848924 — intervention group
Group type: COMPARATOR
Intervention: Placebo (oral administration for 4 weeks)
Number of subjects: 32
Study 9085967 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg
Number of subjects: 0
Study 9085967 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 16 mg
Number of subjects: 0
Study 9085967 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8229102 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered Quality-of-Life after Myocardial Infarction (QLMI) questionnaire
Number of subjects: 0
Study 31777212 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin (0.4 mg/d) plus NSAID
Number of subjects: 0
Study 31777212 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus NSAID
Number of subjects: 0
Study 29893296 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral terbinafine (5mg/kg/day) and topical terbinafine 1% applied twice daily for 4 weeks
Number of subjects: 500
Study 27515978 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab IV (0.03-10 mg/kg)
Number of subjects: 71
Study 27515978 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab SC (10-300 mg)
Number of subjects: 71
Study 27515978 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab IV and SC
Number of subjects: 71
Study 27515978 — intervention group
Group type: COMPARATOR
Intervention: Placebo SC (10, 30, 100, 300 mg)
Number of subjects: 71
Study 25102704 — intervention group
Group type: EXPERIMENTAL
Intervention: Group V - single-stage surgery (radical excision of the tumor with sentinel lymph node biopsy)
Number of subjects: 100
Study 25102704 — intervention group
Group type: COMPARATOR
Intervention: Group D - two-stage surgery (initial diagnostic excision followed by radical re-excision and sentinel lymph node biopsy)
Number of subjects: 100
Study 23281755 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy diet
Number of subjects: 196
Study 23281755 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial diet
Number of subjects: 196
Study 23281755 — intervention group
Group type: EXPERIMENTAL
Intervention: Low energy diet
Number of subjects: 196
Study 23281755 — intervention group
Group type: EXPERIMENTAL
Intervention: Restricted high energy feed
Number of subjects: 196
Study 23281755 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy feed ad libitum
Number of subjects: 196
Study 23281755 — intervention group
Group type: EXPERIMENTAL
Intervention: Chickens slaughtered at 2000 g
Number of subjects: 196
Study 23281755 — intervention group
Group type: EXPERIMENTAL
Intervention: Chickens slaughtered at 1500 g
Number of subjects: 196
Study 23281755 — intervention group
Group type: EXPERIMENTAL
Intervention: Male broilers
Number of subjects: 196
Study 23281755 — intervention group
Group type: EXPERIMENTAL
Intervention: Female broilers
Number of subjects: 196
Study 20624670 — intervention group
Group type: EXPERIMENTAL
Intervention: Fagerström Test for Nicotine Dependence (FTND)
Number of subjects: 73
Study 20624670 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised Fagerström Test for Nicotine Dependence (FTND)
Number of subjects: 73
Study 20624670 — intervention group
Group type: EXPERIMENTAL
Intervention: Hooked on Nicotine Checklist (HONC)
Number of subjects: 73
Study 18390635 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) therapy for 6 weeks
Number of subjects: 46
Study 18390635 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 16199251 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefdinir (once daily n = 569 or twice daily n = 1086) for 5 or 10 days
Number of subjects: 2751
Study 16199251 — intervention group
Group type: COMPARATOR
Intervention: Penicillin (4 times daily n = 1096) for 10 days
Number of subjects: 2751
Study 12451319 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (10 or 20 mg/d)
Number of subjects: 50
Study 12451319 — intervention group
Group type: COMPARATOR
Intervention: Normolipidemic control group
Number of subjects: 50
Study 10514023 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg/day
Number of subjects: 19185
Study 10514023 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 325 mg/day
Number of subjects: 19185
Study 7476741 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 ml of plain water two and half hours before surgery (Group 1)
Number of subjects: 40
Study 7476741 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group 2) - continued overnight fast
Number of subjects: 40
Study 7476741 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group 3) - non-pregnant patients continued overnight fast
Number of subjects: 40
Study 2014108 — intervention group
Group type: EXPERIMENTAL
Intervention: Apraclonidine 1%
Number of subjects: 260
Study 2014108 — intervention group
Group type: COMPARATOR
Intervention: Acetazolamide 250 mg
Number of subjects: 260
Study 2014108 — intervention group
Group type: COMPARATOR
Intervention: Dipivefrin 0.1%
Number of subjects: 260
Study 2014108 — intervention group
Group type: COMPARATOR
Intervention: Pilocarpine hydrochloride 4%
Number of subjects: 260
Study 2014108 — intervention group
Group type: COMPARATOR
Intervention: Timolol maleate 0.5%
Number of subjects: 260
Study 7255001 — intervention group
Group type: EXPERIMENTAL
Intervention: Brazelton Neonatal Behavioral Assessment Scale and Mother's Assessment of the Behavior of Her Infant Scale (MABI)
Number of subjects: 30
Study 7255001 — intervention group
Group type: COMPARATOR
Intervention: Control group (no observation of Brazelton scale, completed questionnaire on developmental milestones)
Number of subjects: 30
Study 30684794 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 49
Study 30684794 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 49
Study 28836341 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose-formulated recombinant FVIII prophylaxis
Number of subjects: 84
Study 28836341 — intervention group
Group type: COMPARATOR
Intervention: On-demand therapy (OD)
Number of subjects: 84
Study 25499095 — intervention group
Group type: EXPERIMENTAL
Intervention: Caltrate 600 mg elemental calcium; 125 IU vitamin D3, 1 tablet/day
Number of subjects: 0
Study 25499095 — intervention group
Group type: EXPERIMENTAL
Intervention: Caltrate 600 mg elemental calcium; 125 IU vitamin D3, 2 tablets/day
Number of subjects: 0
Study 25499095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23611386 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-adjusting file (SAF) instrumentation
Number of subjects: 36
Study 23611386 — intervention group
Group type: EXPERIMENTAL
Intervention: ProFile instrumentation
Number of subjects: 36
Study 23611386 — intervention group
Group type: EXPERIMENTAL
Intervention: K-file instrumentation
Number of subjects: 36
Study 23611386 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 36
Study 22416402 — intervention group
Group type: COMPARATOR
Intervention: Ringer solution and 10% glucose solution (1:1 ratio)
Number of subjects: 139
Study 22416402 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterofundin-G-5
Number of subjects: 139
Study 22416402 — intervention group
Group type: EXPERIMENTAL
Intervention: Remaksol (800 ml/day)
Number of subjects: 139
Study 19827183 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal competence-standards set by the experimenter
Number of subjects: 240
Study 19827183 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-generated standards by participants
Number of subjects: 240
Study 19827183 — intervention group
Group type: COMPARATOR
Intervention: Control conditions (no scores given)
Number of subjects: 240
Study 17368247 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic hysterectomy
Number of subjects: 59
Study 17368247 — intervention group
Group type: COMPARATOR
Intervention: Abdominal hysterectomy
Number of subjects: 59
Study 15196263 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of p336‐351 linked to cholera toxin B subunit (CTB), 3 times weekly, followed by gradual withdrawal of immunosuppressive drugs.
Number of subjects: 8
Study 15196263 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of p336‐351 linked to cholera toxin B subunit (CTB)
Number of subjects: 8
Study 15196263 — intervention group
Group type: COMPARATOR
Intervention: Patients with relapsed uveitis
Number of subjects: 8
Study 11476424 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric overload training (12-week treatment protocol)
Number of subjects: 40
Study 11476424 — intervention group
Group type: COMPARATOR
Intervention: Control group (no eccentric overload training)
Number of subjects: 40
Study 11476424 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric overload training (6-week evaluation)
Number of subjects: 40
Study 9129517 — intervention group
Group type: COMPARATOR
Intervention: Unweighted prosthetic limb
Number of subjects: 8
Study 9129517 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosthetic limb with 0.68 kg added mass
Number of subjects: 8
Study 9129517 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosthetic limb with 1.34 kg added mass
Number of subjects: 8
Study 8164118 — intervention group
Group type: EXPERIMENTAL
Intervention: ePTFE + DFDBA
Number of subjects: 6
Study 8164118 — intervention group
Group type: COMPARATOR
Intervention: ePTFE alone
Number of subjects: 6
Study 3171265 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical vagotomy (0.5 mg of atropine and 50 mg of hexamethonium bromide, injected three times at two hour intervals intramuscularly)
Number of subjects: 28
Study 3171265 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical vagotomy
Number of subjects: 28
Study 3171265 — intervention group
Group type: COMPARATOR
Intervention: Control (no medical vagotomy)
Number of subjects: 28
Study 29664979 — intervention group
Group type: COMPARATOR
Intervention: Standard ILM Peel (SIP)
Number of subjects: 100
Study 29664979 — intervention group
Group type: EXPERIMENTAL
Intervention: Inverted ILM Flap Technique (IFT)
Number of subjects: 100
Study 28974247 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 218
Study 28974247 — intervention group
Group type: COMPARATOR
Intervention: Superficial acupuncture
Number of subjects: 218
Study 26296394 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound results sent to the referring physician
Number of subjects: 120
Study 26296394 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound results not sent to the referring physician
Number of subjects: 120
Study 23211358 — intervention group
Group type: COMPARATOR
Intervention: No CAD
Number of subjects: 16451
Study 23211358 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonobstructive CAD
Number of subjects: 16451
Study 23211358 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstructive CAD (≥50% stenosis)
Number of subjects: 16451
Study 23211358 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstructive CAD among Caucasians
Number of subjects: 16451
Study 23211358 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstructive CAD among Africans
Number of subjects: 16451
Study 23211358 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstructive CAD among East Asians
Number of subjects: 16451
Study 23211358 — intervention group
Group type: COMPARATOR
Intervention: East Asians compared to other ethnicities
Number of subjects: 16451
Study 21601833 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (60 mg once a day)
Number of subjects: 19
Study 21601833 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 18301342 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus (SRL)
Number of subjects: 69
Study 16525222 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillators (ICDs) for secondary prevention
Number of subjects: 0
Study 16525222 — intervention group
Group type: COMPARATOR
Intervention: Pharmacologic therapy
Number of subjects: 0
Study 14756233 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO2) exposure at 2.5 atmospheres absolute for 90 min
Number of subjects: 40
Study 10871716 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized EORTC QLQ‐C30 questionnaire
Number of subjects: 0
Study 10871716 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study 8674333 — intervention group
Group type: EXPERIMENTAL
Intervention: Hygroster (group 1, n = 7)
Number of subjects: 14
Study 8674333 — intervention group
Group type: EXPERIMENTAL
Intervention: Hygrobac-S (group 2, n = 7)
Number of subjects: 14
Study 8674333 — intervention group
Group type: COMPARATOR
Intervention: Standard heated hot water humidifier (control)
Number of subjects: 14
Study 1687129 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 12 micrograms b.i.d.
Number of subjects: 18
Study 1687129 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol 200 micrograms b.i.d.
Number of subjects: 18
Study 1687129 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol (with inhaled steroids reintroduced)
Number of subjects: 18
Study 6376908 — intervention group
Group type: EXPERIMENTAL
Intervention: High opsonic activity against S. epidermidis in peritoneal dialysis effluent
Number of subjects: 17
Study 6376908 — intervention group
Group type: COMPARATOR
Intervention: Low opsonic activity against S. epidermidis in peritoneal dialysis effluent
Number of subjects: 17
Study 6376908 — intervention group
Group type: COMPARATOR
Intervention: Peritoneal dialysis effluent
Number of subjects: 17
Study 6376908 — intervention group
Group type: COMPARATOR
Intervention: Peritonitis episodes
Number of subjects: 17
Study 29717908 — intervention group
Group type: EXPERIMENTAL
Intervention: GreenLight laser vaporization (Group A)
Number of subjects: 150
Study 29717908 — intervention group
Group type: EXPERIMENTAL
Intervention: Thulium laser enucleation (Group B)
Number of subjects: 150
Study 26385187 — intervention group
Group type: EXPERIMENTAL
Intervention: ARV metal stent (ARVMS)
Number of subjects: 77
Study 26385187 — intervention group
Group type: COMPARATOR
Intervention: Conventional covered SEMS (cSEMS)
Number of subjects: 77
Study 24597915 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal feedback report distributed to clients and counselors
Number of subjects: 79
Study 24597915 — intervention group
Group type: COMPARATOR
Intervention: Personal feedback report distributed only to clients
Number of subjects: 79
Study 24597915 — intervention group
Group type: COMPARATOR
Intervention: No personal feedback report
Number of subjects: 79
Study 23740589 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Circuit Training (FCT)
Number of subjects: 51
Study 23740589 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 51
Study 19346013 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump surgery
Number of subjects: 26
Study 19346013 — intervention group
Group type: COMPARATOR
Intervention: On-pump surgery
Number of subjects: 26
Study 19346013 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 26
Study 19049377 — intervention group
Group type: EXPERIMENTAL
Intervention: BIAsp 30
Number of subjects: 32
Study 19049377 — intervention group
Group type: EXPERIMENTAL
Intervention: BIAsp 50
Number of subjects: 32
Study 19049377 — intervention group
Group type: EXPERIMENTAL
Intervention: BIAsp 70
Number of subjects: 32
Study 19049377 — intervention group
Group type: EXPERIMENTAL
Intervention: IAsp
Number of subjects: 32
Study 15876899 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion sustained-release 300 mg/d
Number of subjects: 53
Study 15876899 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 11042232 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention
Number of subjects: 1504
Study 11042232 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 1504
Study 9035450 — intervention group
Group type: COMPARATOR
Intervention: hypocaloric diet + placebo
Number of subjects: 39
Study 9035450 — intervention group
Group type: EXPERIMENTAL
Intervention: hypocaloric diet + dexfenfluramine
Number of subjects: 39
Study 9035450 — intervention group
Group type: COMPARATOR
Intervention: hypocaloric diet + spiruline + fucus + gelatin
Number of subjects: 39
Study 1494509 — intervention group
Group type: EXPERIMENTAL
Intervention: Paretic arm of patients with spastic stroke
Number of subjects: 103
Study 1494509 — intervention group
Group type: EXPERIMENTAL
Intervention: Paretic arm of patients with flaccid tone
Number of subjects: 103
Study 1494509 — intervention group
Group type: COMPARATOR
Intervention: Blood pressure measurement in unaffected arm
Number of subjects: 103
Study 3887883 — intervention group
Group type: COMPARATOR
Intervention: Cholestyramine
Number of subjects: 18
Study 3887883 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine + Neomycin
Number of subjects: 18
Study 31450853 — intervention group
Group type: EXPERIMENTAL
Intervention: CHW-led multimedia intervention
Number of subjects: 42
Study 31450853 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 42
Study 29308992 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-setting intervention
Number of subjects: 75
Study 29308992 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-setting with mentoring intervention
Number of subjects: 75
Study 27324341 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic SYNBIO(®) vaginal suppositories (Lactobacillus rhamnosus IMC 501(®) and Lactobacillus paracasei IMC 502(®)) administered daily for 7 days
Number of subjects: 35
Study 27324341 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic SYNBIO(®) vaginal suppositories
Number of subjects: 35
Study 24804879 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol levels
Number of subjects: 227
Study 24804879 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate of change in cortisol
Number of subjects: 227
Study 24804879 — intervention group
Group type: EXPERIMENTAL
Intervention: CES-D
Number of subjects: 227
Study 24804879 — intervention group
Group type: COMPARATOR
Intervention: Adrenocorticotropin hormone, epinephrine, and norepinephrine
Number of subjects: 227
Study 22290808 — intervention group
Group type: EXPERIMENTAL
Intervention: CCSP (self-management comprehensive coping strategy program)
Number of subjects: 110
Study 22290808 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 110
Study 20202012 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT) procedure
Number of subjects: 360
Study 18367110 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive nephrectomy followed by interferon treatment
Number of subjects: 0
Study 18367110 — intervention group
Group type: COMPARATOR
Intervention: Tyrosine kinase inhibitors (TKIs)
Number of subjects: 0
Study 16846328 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention for participants with high or moderate levels of extraversion
Number of subjects: 697
Study 16846328 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher perceived risk at baseline
Number of subjects: 697
Study 16846328 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher perceived risk
Number of subjects: 697
Study 12798887 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot triptorelin for 8 weeks before myomectomy
Number of subjects: 100
Study 12798887 — intervention group
Group type: COMPARATOR
Intervention: Immediate surgery
Number of subjects: 100
Study 10834688 — intervention group
Group type: EXPERIMENTAL
Intervention: Hygroscopic HME (Aqua+) changed every 24 hrs (HHME‐24)
Number of subjects: 220
Study 10834688 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrophobic HME (Duration HME) changed every 120 hrs (HME‐120)
Number of subjects: 220
Study 10834688 — intervention group
Group type: EXPERIMENTAL
Intervention: Hygroscopic HME (Aqua+) changed every 120 hrs (HHME‐120)
Number of subjects: 220
Study 8993854 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin receptor antagonists (AT1 antagonists)
Number of subjects: 0
Study 8993854 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin receptor antagonists (AT1 antagonists) with diuretic
Number of subjects: 0
Study 8993854 — intervention group
Group type: COMPARATOR
Intervention: ACE inhibitors
Number of subjects: 0
Study 8993854 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term studies
Number of subjects: 0
Study 1614693 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 100
Study 1614693 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanic acid
Number of subjects: 100
Study 4033401 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydration (D) with 40 mg of furosemide
Number of subjects: 8
Study 4033401 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydration (D) during treadmill exercise
Number of subjects: 8
Study 4033401 — intervention group
Group type: COMPARATOR
Intervention: Normally hydrated (H) during treadmill exercise
Number of subjects: 8
Study 31860106 — intervention group
Group type: EXPERIMENTAL
Intervention: Top-cited articles in nonspecialty journals
Number of subjects: 278846
Study 31860106 — intervention group
Group type: COMPARATOR
Intervention: Top-cited articles in OBGYN journals
Number of subjects: 278846
Study 29244956 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO
Number of subjects: 13
Study 29244956 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA
Number of subjects: 13
Study 29244956 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO+BCAA
Number of subjects: 13